The global cerebral oximetry monitoring market size reached USD 89.3 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 156.0 Million by 2033, exhibiting a growth rate (CAGR) of 6.07% during 2025-2033. The rising incidence of neurological disorders, the rising expenditure capacities of consumers, and the growing awareness regarding the early detection of cerebral hypoxia represent some of the key factors driving the market.
Report Attribute
|
Key Statistics
|
---|---|
Base Year
|
2024
|
Forecast Years
|
2025-2033
|
Historical Years
|
2019-2024
|
Market Size in 2024
|
USD 89.3 Million |
Market Forecast in 2033
|
USD 156.0 Million |
Market Growth Rate (2025-2033) | 6.07% |
Cerebral oximetry monitoring and non-invasive techniques are used to measure the levels of oxygen saturation in the blood. The setup consists of an oximeter probe attached to a monitor cable that is connected to a cerebral oximeter monitor. It involves placing a probe on the forehead or scalp, which uses near-infrared light to measure the amount of oxygen in the blood. Cerebral oximetry monitoring is widely used to monitor tissue oxygen saturation, which reflects hemoglobin saturation in arterial, venous, and capillary blood. It assists in reducing the risk of cerebral injury, detecting changes in cerebral oxygenation levels, improving outcomes, and early detection of cerebral hypoxia. Besides this, cerebral oximetry monitoring is a valuable tool in clinical practice that helps to identify and treat any potential problems with blood flow to the brain.
The rising incidence of neurological disorders such as stroke, traumatic brain injury, and dementia across the globe is one of the key factors driving the market growth. Cerebral oximetry monitoring is commonly used to monitor cerebral oxygenation levels in stroke patients and aid in diagnosing and managing the condition. In line with this, the growing awareness regarding the early detection of cerebral hypoxia that helps in timely detection, intervention, and treatment is favoring the market growth. Moreover, the increasing demand for cerebral oximetry monitoring in aortic surgery, arrhythmia surgery, and coronary artery bypass graft surgery (CABG) procedures to minimize the risk of complications and reduce anastomotic leaks is acting as another growth-inducing factor. Apart from this, the introduction of advanced cerebral oximetry monitoring devices that are more accurate, effective, and reliable and alert clinicians about the changes in the patient’s conditions are providing an impetus to the market growth. Additionally, the increasing demand for cerebral oximetry monitoring during the COVID-19 pandemic to monitor the respiratory and neurological status of patients is propelling the market growth. Furthermore, key players are focusing on the development of advanced solutions that offer clinicians reliable, timely, and actionable monitoring to help prevent adverse events and enhance patient care and outcomes, which in turn is creating a positive outlook for the market. Other factors, including the increasing number of cardiac diseases, rising expenditure capacities of consumers, significant growth in the healthcare industry, and extensive research and development (R&D) activities, are anticipated to drive the market growth.
IMARC Group provides an analysis of the key trends in each segment of the global cerebral oximetry monitoring market report, along with forecasts at the global, regional and country levels from 2025-2033. Our report has categorized the market based on age, application, and end use.
Age Insights:
The report has provided a detailed breakup and analysis of the cerebral oximetry monitoring market based on the age. This includes adult and pediatrics.
Application Insights:
A detailed breakup and analysis of the cerebral oximetry monitoring market based on the application has also been provided in the report. This includes cardiac and vascular surgery.
End Use Insights:
The report has provided a detailed breakup and analysis of the cerebral oximetry monitoring market based on the end use. This includes hospitals and clinic. According to the report, hospitals represented the largest segment.
Regional Insights:
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for cerebral oximetry monitoring. Some of the factors driving the North America cerebral oximetry monitoring market included the increasing number of cardiac diseases, significant technological advancements, and the rising expenditure capacities of consumers.
The report has also provided a comprehensive analysis of the competitive landscape in the global cerebral oximetry monitoring market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Edwards Lifesciences, Koninklijke Philips N.V., Masimo Corporation, Medtronic PLC, Nonin Medical Inc, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Million USD |
Ages Covered | Adult, Pediatrics |
Applications Covered | Cardiac Surgery, Vascular Surgery |
End Uses Covered | Hospital, Clinic |
Regions Covered | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered | United States, Canada, Germany, France, United Kingdom, Italy, Spain, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered | Edwards Lifesciences, Koninklijke Philips N.V., Masimo Corporation, Medtronic PLC, Nonin Medical Inc, etc. |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
The global cerebral oximetry monitoring market was valued at USD 89.3 Million in 2024.
We expect the global cerebral oximetry monitoring market to exhibit a CAGR of 6.07% during 2025-2033.
The introduction of advanced cerebral oximetry monitoring devices that are more accurate, effective, and reliable and alert clinicians regarding the changes in the patient’s conditions, along with the rising awareness regarding the early detection of cerebral hypoxia, is primarily driving the global cerebral oximetry monitoring market.
The sudden outbreak of the COVID-19 pandemic has led to the growing adoption of cerebral oximetry monitoring techniques to monitor the respiratory and neurological status of the coronavirus-infected patients.
Based on the end use, the global cerebral oximetry monitoring market can be bifurcated into hospital and clinic. Currently, hospital exhibits a clear dominance in the market.
On a regional level, the market has been classified into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa, where North America currently dominates the global market.
Some of the major players in the global cerebral oximetry monitoring market include Edwards Lifesciences, Koninklijke Philips N.V., Masimo Corporation, Medtronic PLC, Nonin Medical Inc, etc.